2014

AgaMatrix's Zero-Click Software System Receives FDA Clearance

    SALEM, N.H., Nov. 16 /PRNewswire/ -- AgaMatrix, Inc., a privately held
 developer and manufacturer of blood glucose monitoring products, has
 received clearance from the United States Food and Drug Administration
 ("FDA") to sell its Zero-Click(TM) Blood Glucose Data Management System
 ("Zero-Click"). Zero-Click makes it easier for users to download and manage
 data from AgaMatrix's blood glucose monitoring systems ("BGMS").
     This data management product is the only system in the world featuring
 Zero-Click technology, which enables users to effortlessly download data
 via a USB style connection by simply connecting a BGMS to a computer. No
 keyboard or mouse clicks are required for a user to be able to view or
 download data from their meter, much in the same way that a computer
 automatically detects and plays audio CDs.
     Zero-Click can be operated in two modes: a home user mode optimized for
 ease-of-use for self-testers and a professional mode designed for more
 advanced users and multi-patient support by health care providers.
     The software also uniquely features proprietary Virtual Meter(TM)
 technology, which enables users to quickly update numerous settings on
 their BGMS directly from their computer, without having to navigate through
 difficult menus on their meter.
     Zero-Click supports all meters Powered By WaveSense(TM), including the
 WaveSense(TM) KeyNote(TM) BGMS (sold in the US), the Liberty(TM)-branded
 BGMS (sold in the US), the iTest(TM) BGMS (sold in Canada), the Wellion(TM)
 Linus(TM) BGMS (sold in Europe), the GracePro(TM) BGMS (sold in China), and
 other Wave 1(TM) products sold throughout the world.
     "Zero-Click was designed from the ground up with the user in mind.
 Users simply have to plug in their meter to their computer and Zero-Click
 does the rest. At the clinic, care providers no longer have to fumble
 around with a mess of wires while trying to find the serial port and then
 attempting to figure out which program on their desktop to click on," said
 Sonny Vu, EVP of Business Development and Marketing at AgaMatrix.
     AgaMatrix continues to find private label partners in other sales
 channels in the US and abroad for Zero-Click, as well as AgaMatrix's other
 BGMS products.
     Other major makers of BGMS software to serve the $6 billion BGMS market
 include Roche, Johnson and Johnson, Bayer, and Abbott.
     About AgaMatrix
     AgaMatrix, Inc. (www.agamatrix.com) is a consumer medical device
 company headquartered in Salem, New Hampshire that develops and
 manufactures next generation blood glucose monitoring products for the
 diabetes market. The Company's proprietary WaveSense(TM) platform, a suite
 of biosensor and Dynamic Electrochemistry(TM) technologies, enables high
 accuracy glucose sensing. Current products include a meter and strip
 system; future products include a cartridge-based system that fully
 integrates lancets and sensors.
     Powered By WaveSense(TM), WaveSense(TM), Wave 1(TM), KeyNote(TM),
 Zero-Click(TM), Virtual Meter(TM), and their respective logos are
 trademarks of AgaMatrix, Inc. Registered trademarks are the property of
 their respective owners.
 
 

SOURCE AgaMatrix, Inc.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.